Douglas W. Strand PhD

Dr. Strand completed his Ph.D. in the laboratory of David Rowley, Ph.D. in the Department of Molecular and Cellular Biology at Baylor College of Medicine. There he worked on the molecular mechanisms regulating reactive stroma in prostate cancer. From there Dr. Strand moved on to the laboratory of Simon Hayward, Ph.D. in the Urology department at Vanderbilt University to perform his post-doctoral training. It was here that Dr. Strand developed an interest in solving the cellular and molecular pathogenesis of benign prostatic hyperplasia. In 2014, Dr. Strand joined forces with Claus Roehrborn, MD, chair of the Urology department at UT Southwestern and a world-renowned expert in BPH treatment. Dr. Strand has developed an unparalleled human tissue biorepository that is used for his translational research program and is actively pursuing molecular targets for the development of novel medical treatments for this widespread disease.